Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD and Safety of QDX (Topiramate) in Healthy Korean Males
NCT04401137Phase 1Completed
- Sponsor
- SK Chemicals
- Start
- Jul 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of topiramate in migraine (5 arms), sponsored by SK Chemicals. Primary endpoints: Capsaicin-Induced Dermal Blood Flow, Area Under the Plasma Concentration-time Curve (AUC[0-T] and AUClast) and 2 more. Started Jul 2020; status: completed.
02
Drugs
topiramate
03
Conditions
migraine
Beyond the preview
Go deeper on NCT04401137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04401137.